Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

National Diabetes Week: now is the time to help people stay...

ADVERTORIAL BY GLUCERNA® It can be challenging for those with impaired glucose tolerance or insulin resistance to maintain a healthy, low GI diet; especially considering...

An innovative, effective OTC solution to scalp pruritus

Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Harnessing different abilities

Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...